Bronchopulmonary Dysplasia

This second edition provides a comprehensive framework for understanding the pathogenesis, clinical aspects and management of Bronchopulmonary Dysplasia (BPD). The book provides updated and new information over the last decade covering all pulmonary aspects about BPD, which is the most common chronic lung disease affecting infants. This one-stop resource is written by an international group of leading scientists and clinicians in the field, and chapters discuss the most recent developments in the basic research, translational, clinical and novel therapeutic aspects of the disease. Topics include role of hyperoxia, pre- and post-natal inflammation, and genetics and biomarkers of BPD are included, as well as non-invasive ventilation techniques, nutrition, radiology and pulmonary hypertension from pre-term birth to adulthood. The book closes with an in-depth look at emerging novel therapeutic options for the prevention of BPD. All the chapters from the 1st edition have been updated and 3 new chapters have been added. Bronchopulmonary Dysplasia is an essential volume for all students, trainees, neonatologists, pediatric pulmonologists, and scientists interested in the developmental disorders of the lung.

The only book available that comprehensively covers all aspects of Bronchopulmonary Dysplasia Provides information about emerging therapeutic strategies Incorporates long-term pulmonary outcomes

Autorentext

Vineet Bhandari, MBBS, MD, DM, completed his medical school from the Armed Forces Medical College, Pune, India, followed by Pediatric residencies and Neonatology fellowships from the Post Graduate Institute of Medical Education and Research, Chandigarh, India and the University of Connecticut, USA. He worked at the Albert Einstein Medical Center in Philadelphia and Yale-New Haven Children's Hospital in New Haven, CT for ~20 years, before becoming the Chief, Department of Neonatal-Perinatal Medicine at St. Christopher's Hospital for Children / Hahnemann University Hospital / Temple University Hospital, Philadelphia, PA and a Professor of Pediatrics, Obstetrics and Gynecology at Drexel University College of Medicine in 2015. He joined as the Division Head of Neonatology at The Children's Regional Hospital at Cooper in 2020. His current academic appointment is as a Vice Chair of Pediatrics for Faculty Development; Professor of Pediatrics, Obstetrics and Gynecology, and Biomedical Sciences at Cooper Medical School of Rowan University, Camden, NJ. He has edited 3 books (Manual of Neonatology, Bronchopulmonary Dysplasia and Tantalizing Therapeutics in Bronchopulmonary Dysplasia) and authored over 380 book chapters and original research articles. He has been continuously funded by the NIH since 2003. He has presented his research in many national and international conferences.

Inhalt

Part I. BPD: Basic Research.- Chapter 1. Hyperoxia in the pathogenesis of Bronchopulmonary Dysplasia.- Chapter 2. Invasive ventilation in the pathogenesis of Bronchopulmonary Dysplasia.- Chapter 3. Antenatal and Postnatal Inflammatory Factors in the Pathogenesis of Bronchopulmonary Dysplasia.- Chapter 4. Mycoplasma in Bronchopulmonary Dysplasia.- Chapter 5. COPD following Bronchopulmonary Dysplasia.- Part II. BPD: Translational Aspects.- Chapter 6. Genetics of Bronchopulmonary Dysplasia: A Clinical Perspective.- Chapter 7. Biomarkers of Bronchopulmonary Dysplasia.- Chapter 8. Pathology of Bronchopulmonary Dysplasia.- Part III. BPD: Clinical Aspects.- Chapter 9. Bronchopulmonary Dysplasia: Definitions and Epidemiology.- Chapter 10. Oxygen Modulation and Bronchopulmonary Dysplasia: From the Delivery Room and Beyond.- Chapter 11. Prevention and Management of Bronchopulmonary Dysplasia in the Tiny Baby.- Chapter 12. Non-invasive ventilation for prevention of Bronchopulmonary Dysplasia.- Chapter 13. Nutrition in Bronchopulmonary Dysplasia: in the NICU and beyond.- Chapter 14. Radiology of Bronchopulmonary Dysplasia: from preterm birth to adulthood.- Chapter 15. Pulmonary hypertension in Bronchopulmonary Dysplasia.- Chapter 16. Current drug treatment for Bronchopulmonary Dysplasia.- Chapter 17. Post-NICU management of the BPD.- Chapter 18. Pulmonary function in survivors of Bronchopulmonary Dysplasia.- Part IV. BPD: Novel Therapeutic Options.- Chapter 19. Stem cells for the prevention of Bronchopulmonary Dysplasia.- Chapter 20. Less Invasive Surfactant Administration (LISA) for the Prevention of Bronchopulmonary Dysplasia (BPD).- Chapter 21. Anti-inflammatory agents for the prevention of Bronchopulmonary Dysplasia.